Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
Brief Summary: Randomized controlled multi-center study with three arms including 200 patients with low risk endometrial hyperplasia. After confirmed diagnosis the patients will receive one of the following treatments:

1. Provera (Medroxyprogesterone (MPA)/progestin) 10 mg per oral treatment for 6 months 10 day each cycle,
2. MPA 10 mg continuously for 6 months,
3. Mirena (Levonorgestrel) impregnated IUD for 6 months.


Options:
A: Arm Label: MA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Megestrol Acetate | Arm Label: LNG-IUS; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) | Arm Label: MA+LNG-IUS; Type: EXPERIMENTAL; Interventions: Drug: Megestrol Acetate, Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) | Intervention Type: DRUG; Name: Megestrol Acetate; Assigned to Arm(s): MA, MA+LNG-IUS | Intervention Type: DEVICE; Name: Levonorgestrel-releasing Intrauterine System(LNG-IUS); Assigned to Arm(s): LNG-IUS, MA+LNG-IUS
B: Arm Label: MPA for EC without progesterone contraindication; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Arm Label: MPA+Mirena® for EC without contraindication; Type: EXPERIMENTAL; Interventions: Drug: Progesterone, Device: Mirena® | Arm Label: Mirena® for EC without contraindication; Type: EXPERIMENTAL; Interventions: Device: Mirena® | Arm Label: GnRH agonist+Mirena® for EC with contraindication; Type: ACTIVE_COMPARATOR; Interventions: Device: Mirena®, Drug: GnRH agonist | Arm Label: Mirena® for EC with contraindication; Type: EXPERIMENTAL; Interventions: Device: Mirena® | Arm Label: Mirena® for EAH without progesterone contraindication; Type: ACTIVE_COMPARATOR; Interventions: Device: Mirena® | Arm Label: MPA for EAH without progesterone contraindication; Type: EXPERIMENTAL; Interventions: Drug: Progesterone | Arm Label: Mirena® for EAH with progesterone contraindication; Type: ACTIVE_COMPARATOR; Interventions: Device: Mirena® | Arm Label: GnRH-a+Mirena® for EAH with progesterone contraindication; Type: EXPERIMENTAL; Interventions: Device: Mirena®, Drug: GnRH agonist | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): MPA for EAH without progesterone contraindication, MPA for EC without progesterone contraindication, MPA+Mirena® for EC without contraindication | Intervention Type: DEVICE; Name: Mirena®; Assigned to Arm(s): GnRH agonist+Mirena® for EC with contraindication, GnRH-a+Mirena® for EAH with progesterone contraindication, MPA+Mirena® for EC without contraindication, Mirena® for EAH with progesterone contraindication, Mirena® for EAH without progesterone contraindication, Mirena® for EC with contraindication, Mirena® for EC without contraindication | Intervention Type: DRUG; Name: GnRH agonist; Assigned to Arm(s): GnRH agonist+Mirena® for EC with contraindication, GnRH-a+Mirena® for EAH with progesterone contraindication
C: Arm Label: Vaginal Micronized Progesterone; Type: EXPERIMENTAL; Interventions: Drug: Vaginal Micronized Progesterone | Arm Label: LNG-IUS; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-Intrauterine System | Intervention Type: DRUG; Name: Vaginal Micronized Progesterone; Assigned to Arm(s): Vaginal Micronized Progesterone | Intervention Type: DEVICE; Name: Levonorgestrel-Intrauterine System; Assigned to Arm(s): LNG-IUS
D: Arm Label: MPA 10 mg per oral cyclic for 6 months; Type: ACTIVE_COMPARATOR; Interventions: Drug: Provera (medroxyprogesterone/progestin) | Arm Label: MPA 10 mg per os continuous 6 months; Type: ACTIVE_COMPARATOR; Interventions: Drug: Provera (medroxyprogesterone) | Arm Label: LNG-IUD for 6 months; Type: ACTIVE_COMPARATOR; Interventions: Device: Mirena (levonorgestrel) | Intervention Type: DRUG; Name: Provera (medroxyprogesterone/progestin); Assigned to Arm(s): MPA 10 mg per oral cyclic for 6 months | Intervention Type: DRUG; Name: Provera (medroxyprogesterone); Assigned to Arm(s): MPA 10 mg per os continuous 6 months | Intervention Type: DEVICE; Name: Mirena (levonorgestrel); Assigned to Arm(s): LNG-IUD for 6 months

Answer: D